Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938
administrator
studies-show-increased-risk-of-heart-rhythm-problems-with-seizure-and-mental-health-medicine-lamotrigine-(lamictal)-in-patients-with-heart-disease Drug Test
  • February 20, 2025

Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease

Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart…
due-to-risk-of-serious-liver-injury,-fda-restricts-use-of-ocaliva-(obeticholic-acid)-in-primary-biliary-cholangitis-(pbc)-patients-with-advanced-cirrhosis Drug Test
  • February 20, 2025

Due to risk of serious liver injury, FDA restricts use of Ocaliva (obeticholic acid) in primary biliary cholangitis (PBC) patients with advanced cirrhosis

Due to risk of serious liver injury, FDA restricts use of Ocaliva (obeticholic acid) in primary biliary cholangitis (PBC) patients…
fda-warns-that-vapors-from-alcohol-based-hand-sanitizers-can-have-side-effects Drug Test
  • February 20, 2025

FDA warns that vapors from alcohol-based hand sanitizers can have side effects

FDA warns that headache, nausea, and dizziness can occur after applying alcohol-based hand sanitizers to the skin and breathing in…
fda-requests-removal-of-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy;-still-advises-most-pregnant-patients-should-stop-taking-statins Drug Test
  • February 20, 2025

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy. Despite this change, discontinue statins in most pregnant…
fda-requires-warnings-about-increased-risk-of-serious-heart-related-events,-cancer,-blood-clots,-and-death-for-jak-inhibitors-that-treat-certain-chronic-inflammatory-conditions Drug Test
  • February 20, 2025

FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions

Final study results show risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain…
fda-warns-that-getting-alcohol-based-hand-sanitizer-in-the-eyes-can-cause-serious-injury Drug Test
  • February 20, 2025

FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury

FDA is warning that getting alcohol-based hand sanitizer in the eyes can cause serious injury. If this occurs, immediately rinse…
continuing-education-live-events Drug Test
  • February 20, 2025

Continuing Education Live Events

Continuing Education Topics in Public Health
gm-confident-it-can-mitigate-tariffs Medical Supplies
  • February 20, 2025

GM confident it can mitigate tariffs

CFO Paul Jacobson believes the automaker’s experience dealing with past crises, including the global pandemic, will help it find solutions.
stanley-black-&-decker-continues-to-cut-china-production-as-tariffs-emerge Medical Supplies
  • February 20, 2025

Stanley Black & Decker continues to cut China production as tariffs emerge

The manufacturer is bracing for a $10 million to $20 million impact from President Donald Trump’s recent trade announcements.
mucinex-maker-localizes-its-supply-chain Medical Supplies
  • February 20, 2025

Mucinex maker localizes its supply chain

Consumer goods company Reckitt is opening a facility in North Carolina to expand its U.S. manufacturing footprint.